A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Clinical trial NCT04396574 · TERMINATED
Trial details
- NCT number
- NCT04396574
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2025-12-04
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.